AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to ...

Yelena Y. Janjigian, MD, discusses the long-term survival data from the KEYNOTE-811 trial of pembrolizumab plus trastuzumab ...

Professionals share coping strategies for navigating a breast cancer diagnosis, including how to manage difficult emotions, ...

Hollywood legend Val Kilmer has died at 65 from pneumonia following a decade-long health battle. The actor was diagnosed with throat cancer in 2014 and subsequently underwent chemotherapy, radiation ...

New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026. The platform transcribes medical conversations into real ...

Steve and Sara Harrold traveled from the Boston area to Memorial Sloan Kettering Cancer Center (MSK) after he was diagnosed with throat cancer — they were able to call Hope Lodge home throughout his ...

Yelena Y. Janjigian, MD, discusses the standard approval of pembrolizumab plus trastuzumab and chemotherapy for the treatment ...

Actinium Pharmaceuticals (ATNM) has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to expand ...

Memorial Sloan Kettering Cancer Center (MSK) researchers have made several recent discoveries about the clinicopathologic and genomic features predicting higher-risk lung cancer metastatic disease.

Approval from the state for Dana-Farber Cancer Institute to build a freestanding hospital in Longwood Medical Area means progress for the cancer institute’s plan, as well as potential expansion of ...

Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...